Mesenchymal Stromal Cells
No.GRDEC 2014210H
Phase 3 mab active
Quick answer
Mesenchymal Stromal Cells for Chronic Graft-Versus-Host Disease is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Chronic Graft-Versus-Host Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- active